Breaking Headlines

Aug. 16, 2022

How is Frailty Defined in Multiple Myeloma?

Aug. 15, 2022

Myeloma Round Table: Developing a Treatment Strategy — Chicago, April 30, 2022 (Part 2)

Aug. 15, 2022

Why I Chose a Myeloma CAR T Clinical Trial at Relapse

Aug. 15, 2022

Capitalizing Life Insurance to Pay for Care

Aug. 12, 2022

Understanding the Difference Between Chemo and Immunotherapies in Myeloma with Dr. Scott Goldsmith

Aug. 11, 2022

Salt Lake City Myeloma Round Table

Aug. 11, 2022

Cancer Buddies and Coaching

Aug. 11, 2022

Journaling Your Myeloma Story Can Improve Your Health

Aug. 10, 2022

Myeloma Round Table: Essential Information for Newly Diagnosed Patients — Chicago, April 30, 2022 (Part 1)

Aug. 09, 2022

FDA Grants Breakthrough Therapy Designation to Talquetamab for Multiple Myeloma

Aug. 09, 2022

Building Your HealthCare Team

Aug. 09, 2022

HealthTree Foundation Launches New Journaling Feature for Multiple Myeloma Patients

Recent Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Legend Biotechnologies
Bristol Myers Squibb
Abbvie
Genentech
GSK
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811